EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Impact of primary tumor location on survival outcomes and recurrence patterns in patients with stage III non-small cell lung cancer: A retrospective observational study

Chikashi Iwasaki, Eisaku Miyauchi, Takaya Yamamoto, Hisashi Tanaka, Yasuhito Nunomura, Yoshiomi Hatayama, Ryo Morita, Shin Fukui, Tatsunori Ito, Yoko Tsukita, Risa Ebina-Shibuya, Hisatoshi Sugiura

Cancer Treatment and Research Communications · 2026 · 49 · 101472

DOI: 10.1016/j.ctarc.2026.101472 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Treatment and Research Communications, 2026. Verfasst von Chikashi Iwasaki und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Tohoku University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Prognostic impact of primary tumor location in stage III non-small cell lung cancer (NSCLC) remains unclear in the era of concurrent chemoradiotherapy (CCRT) followed by consolidation durvalumab. Whether a lower lobe origin continues to influence survival and recurrence patterns under standardized multimodality therapy has not been fully elucidated. METHODS: This multicenter retrospective study included 136 patients with stage IIIA-IIIC NSCLC treated with definitive CCRT and durvalumab in 2018-2024. Baseline characteristics, recurrence patterns, and survival outcomes were compared between the lower and non-lower lobe groups. Overall survival (OS) and progression-free survival (PFS) were assessed using Kaplan-Meier analyses and Cox proportional hazards models. RESULTS: Patients in the lower lobe group were older and showed differences in concurrent chemotherapy regimens, whereas most other factors were balanced. Lower lobe origin was associated with shorter OS (p = 0.014) and PFS (p = 0.011). On multivariable analysis, lower lobe location remained independently associated with poorer OS (HR, 2.21; 95% CI, 1.29-3.79; p = 0.004) and PFS (HR, 2.03; 95% CI, 1.24-3.33; p = 0.005) after adjustment for clinically relevant covariates. Exploratory analyses suggested more frequent pleural dissemination and liver metastasis in lower-lobe tumors despite similar primary tumor progression. CONCLUSIONS: Lower lobe origin was independently associated with poorer survival in patients with stage III NSCLC treated with CCRT followed by consolidation durvalumab. These findings suggest that primary tumor location may provide additional prognostic information, although its implications for treatment or surveillance strategies require further investigation.

Schlagwörter

Stichwörter der Autor:innen

ChemoradiotherapyImmunotherapyLower lobeNon-small cell lung cancerOverall survivalProgression-free survival

Autor:innen und Institutionen

  • Department of Respiratory Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan.
  • Department of Respiratory Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan. Electronic address: eisaku.miyauchi.b5@tohoku.ac.jp.
  • Department of Radiation Oncology, Tohoku University Graduate School of Medicine, Sendai, Japan.
  • Department of Respiratory Medicine, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.
  • Department of Radiation Oncology, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.
  • Department of Respiratory Medicine, Akita Kosei Medical Center, Akita, Akita, Japan.

Förderung

  • Tohoku University

Zitieren

APA

Iwasaki, C., Miyauchi, E., Yamamoto, T., Tanaka, H., Nunomura, Y., Hatayama, Y., Morita, R., Fukui, S., Ito, T., Tsukita, Y., Ebina-Shibuya, R., & Sugiura, H. (2026). Impact of primary tumor location on survival outcomes and recurrence patterns in patients with stage III non-small cell lung cancer: A retrospective observational study. Cancer Treatment and Research Communications, 49, 101472. https://doi.org/10.1016/j.ctarc.2026.101472

Vancouver

Iwasaki C, Miyauchi E, Yamamoto T, Tanaka H, Nunomura Y, Hatayama Y, et al. Impact of primary tumor location on survival outcomes and recurrence patterns in patients with stage III non-small cell lung cancer: A retrospective observational study. Cancer Treatment and Research Communications. 2026;49:101472. doi:10.1016/j.ctarc.2026.101472

BibTeX
@article{Iwasaki2026,
  author = {Iwasaki, Chikashi and Miyauchi, Eisaku and Yamamoto, Takaya and Tanaka, Hisashi and Nunomura, Yasuhito and Hatayama, Yoshiomi and Morita, Ryo and Fukui, Shin and Ito, Tatsunori and Tsukita, Yoko and Ebina-Shibuya, Risa and Sugiura, Hisatoshi},
  title = {Impact of primary tumor location on survival outcomes and recurrence patterns in patients with stage III non-small cell lung cancer: A retrospective observational study},
  journal = {Cancer Treatment and Research Communications},
  year = {2026},
  volume = {49},
  pages = {101472},
  doi = {10.1016/j.ctarc.2026.101472}
}
Kostenlos starten →